Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 May 1;339(Pt 3):489–495.

Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.

L J Hazell 1, M J Davies 1, R Stocker 1
PMCID: PMC1220181  PMID: 10215584

Abstract

Oxidation of low-density lipoproteins (LDL) is thought to contribute to atherogenesis. Although there is increasing evidence for a role of myeloperoxidase-derived oxidants such as hypochlorite (HOCl), the mechanism by which HOCl modifies LDL remains controversial. Some studies report the protein component to be the major site of attack, whereas others describe extensive lipid peroxidation. The present study addresses this controversy. The results obtained are consistent with the hypothesis that radical-induced oxidation of LDL's lipids by HOCl is a secondary reaction, with most HOCl consumed via rapid, non-radical reaction with apolipoprotein B-100. Subsequent incubation of HOCl-treated LDL gives rise to lipid peroxidation and antioxidant consumption in a time-dependent manner. Similarly, with myeloperoxidase/H2O2/Cl- (the source of HOCl in vivo), protein oxidation is rapid and followed by an extended period of lipid peroxidation during which further protein oxidation does not occur. The secondary lipid peroxidation process involves EPR-detectable radicals, is attenuated by a radical trap or treatment of HOCl-oxidized LDL with methionine, and occurs less rapidly when the lipoprotein was depleted of alpha-tocopherol. The initial reaction of low concentrations of HOCl (400-fold or 800-fold molar excess) with LDL therefore seems to occur primarily by two-electron reactions with side-chain sites on apolipoprotein B-100. Some of the initial reaction products, identified as lysine-residue-derived chloramines, subsequently undergo homolytic (one-electron) reactions to give radicals that initiate antioxidant consumption and lipid oxidation via tocopherol-mediated peroxidation. The identification of these chloramines, and the radicals derived from them, as initiating agents in LDL lipid peroxidation offers potential new targets for antioxidative therapy in atherogenesis.

Full Text

The Full Text of this article is available as a PDF (158.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnhold J., Wiegel D., Richter O., Hammerschmidt S., Arnold K., Krumbiegel M. Modification of low density lipoproteins by sodium hypochlorite. Biomed Biochim Acta. 1991;50(8):967–973. [PubMed] [Google Scholar]
  2. Berliner J. A., Heinecke J. W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20(5):707–727. doi: 10.1016/0891-5849(95)02173-6. [DOI] [PubMed] [Google Scholar]
  3. Bernofsky C., Bandara B. M., Hinojosa O., Strauss S. L. Hypochlorite-modified adenine nucleotides: structure, spin-trapping, and formation by activated guinea pig polymorphonuclear leukocytes. Free Radic Res Commun. 1990;9(3-6):303–315. doi: 10.3109/10715769009145689. [DOI] [PubMed] [Google Scholar]
  4. Bowry V. W., Ingold K. U., Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J. 1992 Dec 1;288(Pt 2):341–344. doi: 10.1042/bj2880341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bowry V. W., Mohr D., Cleary J., Stocker R. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem. 1995 Mar 17;270(11):5756–5763. doi: 10.1074/jbc.270.11.5756. [DOI] [PubMed] [Google Scholar]
  6. Böhlen P., Stein S., Dairman W., Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys. 1973 Mar;155(1):213–220. doi: 10.1016/s0003-9861(73)80023-2. [DOI] [PubMed] [Google Scholar]
  7. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994 Jul;94(1):437–444. doi: 10.1172/JCI117342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Desser R. K., Himmelhoch S. R., Evans W. H., Januska M., Mage M., Shelton E. Guinea pig heterophil and eosinophil peroxidase. Arch Biochem Biophys. 1972 Feb;148(2):452–465. doi: 10.1016/0003-9861(72)90164-6. [DOI] [PubMed] [Google Scholar]
  9. Diaz M. N., Frei B., Vita J. A., Keaney J. F., Jr Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997 Aug 7;337(6):408–416. doi: 10.1056/NEJM199708073370607. [DOI] [PubMed] [Google Scholar]
  10. Esterbauer H., Dieber-Rotheneder M., Striegl G., Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991 Jan;53(1 Suppl):314S–321S. doi: 10.1093/ajcn/53.1.314S. [DOI] [PubMed] [Google Scholar]
  11. Folcik V. A., Nivar-Aristy R. A., Krajewski L. P., Cathcart M. K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995 Jul;96(1):504–510. doi: 10.1172/JCI118062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frei B., Gaziano J. M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res. 1993 Dec;34(12):2135–2145. [PubMed] [Google Scholar]
  13. Fu S., Davies M. J., Stocker R., Dean R. T. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 1998 Aug 1;333(Pt 3):519–525. doi: 10.1042/bj3330519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hawkins C. L., Davies M. J. Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J. 1998 Jun 15;332(Pt 3):617–625. doi: 10.1042/bj3320617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hazell L. J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 1996 Mar 15;97(6):1535–1544. doi: 10.1172/JCI118576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hazell L. J., Stocker R. Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein. FEBS Lett. 1997 Sep 15;414(3):541–544. doi: 10.1016/s0014-5793(97)01066-1. [DOI] [PubMed] [Google Scholar]
  17. Hazell L. J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 1993 Feb 15;290(Pt 1):165–172. doi: 10.1042/bj2900165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hazell L. J., van den Berg J. J., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J. 1994 Aug 15;302(Pt 1):297–304. doi: 10.1042/bj3020297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hazen S. L., Heinecke J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997 May 1;99(9):2075–2081. doi: 10.1172/JCI119379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ingold K. U., Bowry V. W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):45–49. doi: 10.1073/pnas.90.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kopprasch S., Leonhardt W., Pietzsch J., Kühne H. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells. Atherosclerosis. 1998 Feb;136(2):315–324. doi: 10.1016/s0021-9150(97)00233-5. [DOI] [PubMed] [Google Scholar]
  22. Kühn H., Belkner J., Zaiss S., Fährenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med. 1994 Jun 1;179(6):1903–1911. doi: 10.1084/jem.179.6.1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Leeuwenburgh C., Hardy M. M., Hazen S. L., Wagner P., Oh-ishi S., Steinbrecher U. P., Heinecke J. W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997 Jan 17;272(3):1433–1436. doi: 10.1074/jbc.272.3.1433. [DOI] [PubMed] [Google Scholar]
  24. Liao L., Aw T. Y., Kvietys P. R., Granger D. N. Oxidized LDL-induced microvascular dysfunction. Dependence on oxidation procedure. Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2305–2311. doi: 10.1161/01.atv.15.12.2305. [DOI] [PubMed] [Google Scholar]
  25. Morton R. E., Evans T. A. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein protein content. Anal Biochem. 1992 Aug 1;204(2):332–334. doi: 10.1016/0003-2697(92)90248-6. [DOI] [PubMed] [Google Scholar]
  26. Neuzil J., Thomas S. R., Stocker R. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med. 1997;22(1-2):57–71. doi: 10.1016/s0891-5849(96)00224-9. [DOI] [PubMed] [Google Scholar]
  27. Panasenko O. M., Arnhold J., Schiller J., Arnold K., Sergienko V. I. Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorous acid. Biochim Biophys Acta. 1994 Dec 8;1215(3):259–266. doi: 10.1016/0005-2760(94)90051-5. [DOI] [PubMed] [Google Scholar]
  28. Panasenko O. M., Briviba K., Klotz L. O., Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch Biochem Biophys. 1997 Jul 15;343(2):254–259. doi: 10.1006/abbi.1997.0171. [DOI] [PubMed] [Google Scholar]
  29. Panasenko O. M., Evgina S. A., Aidyraliev R. K., Sergienko V. I., Vladimirov Y. A. Peroxidation of human blood lipoproteins induced by exogenous hypochlorite or hypochlorite generated in the system of "myeloperoxidase + H2O2 + Cl-". Free Radic Biol Med. 1994 Feb;16(2):143–148. doi: 10.1016/0891-5849(94)90137-6. [DOI] [PubMed] [Google Scholar]
  30. Panzenboeck U., Raitmayer S., Reicher H., Lindner H., Glatter O., Malle E., Sattler W. Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem. 1997 Nov 21;272(47):29711–29720. doi: 10.1074/jbc.272.47.29711. [DOI] [PubMed] [Google Scholar]
  31. Sato K., Niki E., Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys. 1990 Jun;279(2):402–405. doi: 10.1016/0003-9861(90)90508-v. [DOI] [PubMed] [Google Scholar]
  32. Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods Enzymol. 1994;233:469–489. doi: 10.1016/s0076-6879(94)33053-0. [DOI] [PubMed] [Google Scholar]
  33. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  34. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  35. Stelmaszyńska T., Kukovetz E., Egger G., Schaur R. J. Possible involvement of myeloperoxidase in lipid peroxidation. Int J Biochem. 1992;24(1):121–128. doi: 10.1016/0020-711x(92)90237-u. [DOI] [PubMed] [Google Scholar]
  36. TEALE F. W. The ultraviolet fluorescence of proteins in neutral solution. Biochem J. 1960 Aug;76:381–388. doi: 10.1042/bj0760381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Thomas E. L., Jefferson M. M., Grisham M. B. Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines. Biochemistry. 1982 Nov 23;21(24):6299–6308. doi: 10.1021/bi00267a040. [DOI] [PubMed] [Google Scholar]
  38. Winterbourn C. C. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta. 1985 Jun 18;840(2):204–210. doi: 10.1016/0304-4165(85)90120-5. [DOI] [PubMed] [Google Scholar]
  39. Yang C. Y., Gu Z. W., Yang H. X., Yang M., Gotto A. M., Jr, Smith C. V. Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro. Free Radic Biol Med. 1997;23(1):82–89. doi: 10.1016/s0891-5849(96)00624-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES